Drupal.behaviors.print = function(context) {window.print();window.close();}>
MDx/CDx Focus: Trovagene, MD Anderson Work to ID KRAS Mutations in Urine; FDA on Device Identifiers
July 03, 2012
MDx/CDx Focus: Trovagene, MD Anderson Work to ID KRAS Mutations in Urine; FDA on Device Identifiers
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Trovagene, MD Anderson Partner on Transrenal BRAF Mutation Detection
January 3, 2013 / PCR Insider
Trovagene Set to Offer Transrenal KRAS Assay on Bio-Rad dPCR System in January
November 29, 2012 / PCR Insider
Trovagene Using Bio-Rad Digital PCR System for Trans-Renal Pancreatic Cancer MDx
May 31, 2012 / PCR Insider
Trovagene Bets on Digital PCR as Detection Technology for Urine-Based MDx Testing Platform
May 3, 2012 / PCR Insider
With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option
December 12, 2012 / Pharmacogenomics Reporter